Cyclodextrin Complexes for Stable Membrane-Bound Wnt and Hh Proteins

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for obtaining membrane-bound Wingless (Wnt) and Hedgehog (Hh) proteins are not effective in yielding stable and efficacious molecules, as they often result in protein denaturation and limited stability.

Innovation Solution

A complex of lipid-modified proteins, such as Wnt and Hh, is formed with cyclodextrin, stabilized by trehalose, and preserved through lyophilization, allowing long-term storage and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If current methods are used to obtain membrane-bound Wnt and Hh proteins, then the proteins can be extracted, but they undergo denaturation and have limited stability

Engineering Contradiction:
Improveprotein stabilityVSAvoidprotein efficacy
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent introduces cyclodextrin as an intermediary molecule that forms inclusion complexes with membrane-bound Wnt and Hh proteins. The cyclodextrin acts as a mediator that protects the proteins from denaturation while maintaining their biological activity, thereby resolving the contradiction between protein stability and efficacy

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite structure by combining cyclodextrin with lipid-modified Wnt and Hh proteins to form stable inclusion complexes. This composite material approach allows the proteins to maintain their membrane-bound characteristics while gaining enhanced stability and reliability for therapeutic applications

Inventive Principle:
Principle #40Composite materials

2Duration of action of stationary object

If membrane-bound proteins are extracted using conventional methods, then the proteins can be obtained, but they lack long-term storage stability

Engineering Contradiction:
Improvestorage stabilityVSAvoidprotein purification
Core Design Contradiction:
Duration of action of stationary objectVSEase of manufacture

Solution Approach 1:

The patent changes the physical and chemical parameters of the protein preparation by forming cyclodextrin inclusion complexes. This parameter change enables long-term storage stability while maintaining protein activity, allowing the proteins to be stored without immediate loss of function

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent performs preliminary complex formation with cyclodextrin during the protein extraction process. This preliminary action stabilizes the proteins early in the purification process, preventing denaturation during subsequent steps and enabling long-term storage

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method ensures the capture and preservation of lipid-modified proteins, enabling their use in tissue repair, wound healing, skin rejuvenation, and hair growth, with enhanced stability and efficacy.

Implementation Method 1

compositions comprising a complex of lipid-modified proteins and a cyclodextrin

Methodology Applied
Scientific EffectInclusion complex formation:

Implementation Method 2

lipid-modified proteins comprise one or more Wingless (Wnt) or Hedgehog (Hh) proteins associated with a cell membrane lipid

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Implementation Method 3

the composition further comprises at least one kosmotrope. In some embodiments, the at least one kosmotrope is propylene glycol, proline, trehalose, ectoine, or trimethylamine N-oxide

Methodology Applied
Scientific EffectKosmotropic effect:

Implementation Method 4

preserved through lyophilization, allowing long-term storage and stability

Methodology Applied
Scientific EffectLyophilization: Freeze Drying

Data Source

PatentUS20250387314A1Use of cell membrane-bound signaling factors
Publication Date: 2025.12.25 AIVITA BIOMEDICAL INC
  • US20250387314A1 patent drawing
  • US20250387314A1 patent drawing
  • US20250387314A1 patent drawing

AI summary

Disclosed herein are compositions comprising complexes of cyclodextrins and lipid-modified stem cell proteins. Also disclosed are topical compositions the complexes. Methods of using the compositions for the therapeutic purposes are also disclosed as well as methods of producing the compositions.